Highly Potent and Conformal Alpha Emitters Radiotherapy for the Treatment of Solid Cancer Tumors
The Alpha DaRT Treatment
Alpha DaRT enables a highly potent and conformal radiation treatment for solid cancer tumors. Directly inserted into the tumor, the Alpha DaRT seeds release a high-energy dose over a range of several millimeters enabling a focal alpha-radiation treatment that spares the surrounding healthy tissue. The Alpha DaRT treatment has several significant clinical advantages…
The Alpha DaRT Technology
The Alpha DaRT breakthrough technology utilizes Alpha radiation to treat cancer. DaRT (Diffusing Alpha-emitters Radiation Therapy) treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha-emitting atoms into the tumor.
Alpha Tau Medical is currently running clinical trials for:
- Skin Cancer
- Oral Cavity Cancer
- Breast Cancer
The company is working with leading cancer researchers to commence additional trials for further indications.
About Alpha Tau Medical
Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.
